Pacific Biosciences Of California (PACB) Inventory Average (2011 - 2026)

Pacific Biosciences Of California has reported Inventory Average for 16 years, with the latest figure at $50.2 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 11.05% year-over-year to $50.2 million; the trailing twelve-month figure through Mar 2026 stood at $50.2 million (down 11.05% YoY), and the FY2025 full-year result was $54.0 million, down 6.4% from the prior year.
• Inventory Average for Q1 2026 stood at $50.2 million, down from $51.2 million in the prior quarter.
• The five-year high for Inventory Average was $68.0 million in Q2 2024, with the low at $27.1 million in Q1 2022.
• Average Inventory Average over 5 years is $54.3 million, with a median of $56.2 million recorded in 2023.
• Year-over-year, Inventory Average jumped 107.17% in 2023 and dropped 20.66% in 2025.
• Tracing PACB's Inventory Average over 5 years: stood at $46.9 million in 2022, then jumped by 33.08% to $62.5 million in 2023, then dropped by 0.35% to $62.2 million in 2024, then fell by 17.72% to $51.2 million in 2025, then slipped by 2.08% to $50.2 million in 2026.
• The last three Inventory Average figures came in at $50.2 million (Q1 2026), $51.2 million (Q4 2025), and $53.5 million (Q3 2025), per Business Quant data.

Peer Comparison